Semaglutide's Impact on Inflammation in Obesity
Exploring the anti-inflammatory effects of semaglutide beyond weight loss
Topline:
A recent study reveals that the anti-obesity drug semaglutide significantly reduces the inflammatory marker high-sensitivity C-reactive protein (CRP), even in patients who do not experience substantial weight loss. This finding suggests potential anti-inflammatory benefits that may influence cardiovascular health.
Study Details:
The SELECT clinica…
Keep reading with a 7-day free trial
Subscribe to Just Healthcare to keep reading this post and get 7 days of free access to the full post archives.